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There are twenty-five known inherited cardiac arrhythmia susceptibility genes, all of
which encode either ion channel pore-forming subunits or proteins that regulate aspects
of ion channel biology such as function, trafficking, and localization. The human KCNE
gene family comprises five potassium channel regulatory subunits, sequence variants
in each of which are associated with cardiac arrhythmias. KCNE gene products exhibit
promiscuous partnering and in some cases ubiquitous expression, hampering efforts
to unequivocally correlate each gene to specific native potassium currents. Likewise,
deducing the molecular etiology of cardiac arrhythmias in individuals harboring rare KCNE
gene variants, or more common KCNE polymorphisms, can be challenging. In this
review we provide an update on putative arrhythmia-causing KCNE gene variants, and
discuss current thinking and future challenges in the study of molecular mechanisms of
KCNE-associated cardiac rhythm disturbances.
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INTRODUCTION
A quarter of a century ago, Takumi and colleagues discovered a
fraction of rat kidney mRNA that generated an unusual, slow-
activating K+-selective current when injected into Xenopus laevis
oocytes (Takumi et al., 1988). The protein product required for
this slow current has been variously termed “minimal potas-
sium channel” (MinK), “IsK” (for slow potassium current), and
more recently KCNE1—the gene name KCNE1 now being most
commonly also used when referring to the protein product, for
simplicity. We now know that KCNE1 is the founding member of
a five-strong family of single transmembrane domain potassium
channel ancillary (β) subunits (Figures 1, 2) that do not form
currents alone but are essential for generation of some native K+
currents by virtue of formation of heteromeric ion channel com-
plexes with voltage-gated potassium (Kv) channel pore-forming α
subunits (Abbott and Goldstein, 1998). Because KCNE1 was rel-
atively quickly found to be a molecular correlate of the slowly
activating ventricular myocyte K+ current, IKs (Freeman and
Kass, 1993), study of the KCNE family as a whole has historically
been focused primarily on the heart. This is especially true for the
study of the role of KCNE gene variants in human disease.
Although in the new millennium the role of various KCNE
subunits in epithelia has been extensively explored, this work
has been largely conducted using mouse models (Arrighi et al.,
2001; Dedek andWaldegger, 2001; Barriere et al., 2003; Rivas and
Francis, 2005; Roepke et al., 2006, 2009, 2011a,b; Preston et al.,
2010). The existing evidence from human genetics of the neces-
sity for KCNE proteins in extracardiac tissue (Schulze-Bahr et al.,
1997; Tyson et al., 1997) probably represents the tip of the ice-
berg in terms of the actual importance of human KCNE proteins
Abbreviations: AF, atrial fibrillation; BrS, Brugada syndrome; CHO, Chinese
hamster ovary; diLQTS, drug-induced Long QT Syndrome; IKs, cardiac-delayed
rectifier-like K+ current; JLNS, Jervell and Lange-Nielsen syndrome.
to tissues outside the heart, including polarized epithelia. In con-
trast, more than sixty KCNE gene variants have been suggested to
associate with human cardiac arrhythmias. In this mini-review we
summarize current knowledge on arrhythmia-associated KCNE
gene variants and discuss the difficulties in establishing causal-
ity and molecular etiology when dealing with rare diseases and
promiscuous regulatory proteins.
Kv channels play a central role in active repolarization of
all excitable cells, including cardiac myocytes. In human ventri-
cles, three types of Kv channel in particular are important for
timely myocyte repolarization, and also for the action potential
morphology optimal for rhythmic contractions, incorporating a
plateau phase followed by relatively steep phase 3 repolarization
(Figure 1B). During an action potential, membrane depolar-
ization primarily from Na+ influx through voltage-gated Na+
channels is counteracted by a transient outward K+ (Ito) current,
producing the initial repolarization “notch.” Subsequently, slower
delayed rectifier-generated outward K+ currents (IKr and IKs)
counteract inward Ca2+ flux through voltage-gated Ca2+ chan-
nels, modulating the strength of contraction and duration of the
action potential plateau (Sanguinetti and Jurkiewicz, 1990; Niwa
and Nerbonne, 2010).
KCNE REGULATION OF hERG: THE α SUBUNIT UNDERLYING
VENTRICULAR IKr
The “rapidly activating” K+ current (IKr) is the predom-
inant human ventricular repolarization current under nor-
mal circumstances. IKr is generated by channels comprising a
tetramer of hERG α subunits, encoded by the KCNH2 gene.
KCNH2 gene mutations are (together with KCNQ1) one of
the top two identified inherited causes of the cardiac arrhyth-
mia Long QT Syndrome (LQTS), which results from delayed
ventricular myocyte repolarization, manifests as a prolonged
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FIGURE 1 | KCNE subunits and the ventricular myocyte action
potential. (A) Upper, transmembrane topology of Kv α and KCNE
subunits with transmembrane segments numbered; lower, one
suggested stoichiometry of a KCNE-containing Kv channel complex.
Extracellular side is uppermost in each case. (B) Upper, a ventricular
action potential waveform indicating the major ionic currents that
contribute to its morphology and duration; lower, a human surface ECG
waveform showing the QT interval.
FIGURE 2 | Human KCNE1-KCNE5 protein sequence alignments and
gene variants. Image of aligned sequences generated using
http://www.uniprot.org/align. Colors highlight inherited or sporadic
non-synonymous mutations or polymorphisms resulting in single amino acid
changes (changes involving >1 amino acid are omitted). In cases where an
amino acid substitution is associated with LQTS in addition to another
arrhythmia, only the latter is color-coded (see Table S1 for full information).
The predicted transmembrane domain for each subunit is outlined in red.
electrocardiogram QT interval (Figure 1B), and can cause lethal
ventricular fibrillation (Curran et al., 1995; Sanguinetti et al.,
1995). hERG channels exhibit unusual properties that influence
both cardiac electrical function and arrhythmogenesis. First, the
majority of pathologic KCNH2 gene mutations cause loss of
function via protein maturation/trafficking defects rather than
channel conduction or gating defects (Anderson et al., 2006).
Second, upon membrane depolarization, hERG channels open
and then rapidly inactivate. As the membrane begins to repo-
larize, hERG recovers rapidly from inactivation but deactivates
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slowly. This creates an atypical mode of inward rectification
(classic inward rectifier K+ channels being generated instead by
tetramers of two-transmembrane domain α subunits) (Smith
et al., 1996). It ensures that hERG channels pass robust currents
relatively late in the ventricular action potential, to speed phase
3 repolarization, without curtailing the preceding plateau phase.
Third, hERG is highly susceptible to block by drugs from a wide
range of chemical structures, making it the bane of pharmaceuti-
cal companies attempting to bring tomarket otherwise efficacious
drugs that fail safety standards because they inhibit hERG and
therefore are predicted (or demonstrated) to cause drug-induced
LQTS (diLQTS) (Sanguinetti et al., 1995; Chen et al., 2002).
hERG channels are modulated by both KCNE1 and KCNE2
(originally named MinK-related Protein 1 or MiRP1) in vitro and
potentially also in human heart (McDonald et al., 1997; Abbott
et al., 1999). Currents generated by expression of hERG alone in
heterologous expression systems recapitulate most of the func-
tional properties of native IKr, including the unusual (for an
S4 family α subunit) inward rectification and the exquisite drug
sensitivity (Sanguinetti et al., 1995). However, KCNE1 forms het-
eromeric complexes with hERG and increases hERG currents by
an as yet unknown mechanism when the two proteins are co-
expressed in COS cells (McDonald et al., 1997). In addition,
inherited KCNE1 mutants associated with human LQTS impair
hERG function and/or trafficking (Table S1). These findings sug-
gest that KCNE1 modulates hERG in vivo in at least some areas of
the ventricle (Bianchi et al., 1999).
hERG also forms heteromeric complexes with KCNE2, when
the two are co-expressed in Chinese Hamster Ovary (CHO)
cells. When co-expressed in either Xenopus oocytes or CHO cells,
KCNE2 alters hERG function, shifting the voltage dependence of
activation, decreasing unitary conductance, and speeding deac-
tivation. Importantly, inherited gene variants in human KCNE2
that are associated with LQTS impair hERG gating, which would
be predicted to delay ventricular repolarization as is seen in LQTS
(Abbott et al., 1999) (Table S1). More strikingly, KCNE2 gene
variants associated with drug-induced LQTS (diLQTS) in some
cases increase the sensitivity of hERG in vitro to block by the spe-
cific drug that precipitated the arrhythmic episode in vivo (Abbott
et al., 1999; Sesti et al., 2000).
This is highly supportive of a role for KCNE2 in direct reg-
ulation of hERG channels in human ventricular myocardium.
Indeed, KCNE2-rERG complexes have been isolated from rat
heart and a plethora of other evidence suggests that KCNE2 reg-
ulates ERG in the hearts of several species (Jiang et al., 2004;
McCrossan et al., 2009; Zhang et al., 2011). However, the debate
that has surrounded the existence and necessity of hERG-KCNE2
complexes in human heart highlights the difficulties in nailing
down the molecular correlates of multi-subunit channels. This
problem is exacerbated when considering human heart, which
compared to animal studies, involves more restrictions in tissue
availability and less practicable experimental options. Temporal
dynamism and spatial diversity in the makeup of these complexes
(as almost certainly occurs with KCNE-containing channels) also
stymies this research, as does the fact (as in the case of KCNE2-
hERG) that the effects of KCNE2 on hERG are relatively subtle
and may be expression system-dependent. Furthermore, when
disease associations are relatively rare and the subunits involved
exhibit promiscuous partnering, even human genetics does not
automatically uncover the precise functional role of a regulatory
subunit. Mouse models have been useful in discovering physio-
logical and arrhythmogenic roles for KCNE subunits and their
disruption (Temple et al., 2005; Roepke et al., 2008; Hu et al.,
2013) but come with the caveat, especially for the heart, that there
is a big divide between mouse and human heart in terms of phys-
iology, the primary repolarizing currents, and their molecular
underpinnings (Nerbonne et al., 2001).
KCNE MODULATION OF KCNQ1: THE α SUBUNIT
UNDERLYING HUMAN VENTRICULAR IKs
KCNQ1 is the pore-forming subunit of cardiac IKs, a slow-
activating K+ current that, in human ventricles, may act primar-
ily as a back-up for IKr when the latter is diminished by e.g.,
drug block, mutation, or during periods of increased heart-rate
(Barhanin et al., 1996; Sanguinetti et al., 1996; Silva and Rudy,
2005). KCNQ1 is the endogenous Xenopus laevis oocyte α sub-
unit that was awakened by injected KCNE1 in Takumi’s original
discovery of the KCNE family. It took a further 8 years before the
cloning of human and Xenopus KCNQ1 (then termed KvLQT1)
was reported (Barhanin et al., 1996; Sanguinetti et al., 1996),
KCNQ1 was linked to LQTS (Wang et al., 1996), and the KCNE1
functionality and IKs molecular correlate conundrums solved.
Or were they? We know for certain that ventricular KCNQ1-
KCNE1 complexes exist in the hearts of some large mammals, and
almost certainly contribute to human ventricular myocyte repo-
larization. Loss-of-function gene variants in either gene reduce
repolarizing force and delay ventricular repolarization, causing
LQTS, particularly manifest (for KCNQ1 mutants) during peri-
ods of sympathetic stimulation such as while swimming (Wang
et al., 1996; Tyson et al., 1997; Ackerman et al., 1999).
However, it is also highly likely that other KCNQ1-KCNE
channels help to repolarize some ventricular myocytes in human
heart, and that KCNE1 regulates other Kv α subunits in human
heart as well. This means that KCNE1-associated LQTS (termed
LQT5) could be much more complicated than just disruption
of ventricular KCNQ1-KCNE1. Another fly in the ointment for
those wishing to rationalize the genetics of ventricular arrhyth-
mias is that KCNQ1-hERG complexes almost certainly exist in
human heart and loss-of-function variants in either subunit may
affect the function of the other (Ehrlich et al., 2004; Ehrlich, 2010;
Ren et al., 2010). Add to this the notion that different KCNEs
may participate in the same multi-subunit channel complex with
KCNQ1 (Wu et al., 2006) and the riddle that is the molecu-
lar etiology of KCNE-associated arrhythmogenesis becomes ever
more enigmatic. KCNQ1 can be modulated by all five known
human KCNEs, with diverse functional outcomes (McCrossan
and Abbott, 2004). The stoichiometry of KCNQ1-KCNE com-
plexes is still under debate, but there are almost certainly four
KCNQ1 α subunits in complex with 2–4 KCNE1 subunits (and
possibly a variable number of KCNE1 subunits within these lim-
its, depending upon expression levels) (Chen et al., 2003; Nakajo
et al., 2010; Yu et al., 2013).
KCNE1 slows KCNQ1 activation 5–10-fold, eliminates its
inactivation, increases unitary conductance and tweaks ion
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selectivity and pharmacology (Sesti and Goldstein, 1998).
Strikingly, KCNE1 also strongly modulates KCNQ1 affinity for
PIP2 (an important regulatory factor) (Loussouarn et al., 2003),
and KCNE1 mediates protein kinase C-stimulated clathrin-
mediated endocytosis of KCNQ1-KCNE1 (Kanda et al., 2011).
KCNE1 also regulates KCNQ1 in the inner ear, which is why
some individuals harboring loss-of-function mutants in KCNQ1
or KCNE1 in both alleles succumb to Jervell and Lange-Nielsen
Syndrome (JLNS), comprising both LQTS and sensorineural
deafness. Rather than mediating repolarization, in the inner ear
KCNQ1-KCNE1 probably serves primarily to maintain a K+-rich
environment in the endolymph (Wangemann et al., 1995; Vetter
et al., 1996; Wangemann et al., 1996).
KCNE2 performs electrical alchemy with KCNQ1, convert-
ing it into a constitutively active channel that has lost much of
its voltage dependence (Tinel et al., 2000). KCNQ1-KCNE2 is
especially important in various polarized epithelia (Abbott, 2012)
but could also be present in human heart. Some atrial fibrilla-
tion (AF)-associated KCNQ1 and KCNE2 human gene variants
augment KCNQ1-KCNE2 currents (which are typically much
smaller in terms of outward current even than KCNQ1 alone) and
would therefore be predicted to shorten the atrial action poten-
tial, thought to predispose to AF (Yang et al., 2004) (Table S1).
KCNE3, one variant of which also associates with AF (Zhang
et al., 2005) has broadly similar effects on KCNQ1, but the resul-
tant currents are much larger than those of KCNQ1-KCNE2
and important in different epithelial cells to those of KCNQ1-
KCNE2 (Schroeder et al., 2000). Either heteromer type could
contribute to background K+ currents in human cardiomyocytes
but this has yet to be established. Similarly, KCNE2 and KCNE3
could each contribute to tripartite complexes with KCNQ1 and
KCNE1, or to variegated macromolecular assemblies also includ-
ing hERG, with potentially complex and dynamic functional
attributes. Understanding the expression and regulation of such
complexes in vivo is challenging but could lead to development
of anti-arrhythmic drugs with, for example, improved spatial
selectivity (Yu et al., 2013).
KCNE4 inhibits KCNQ1 and may potentially serve this func-
tion in vivo in human heart (Grunnet et al., 2002, 2005). KCNQ1-
KCNE5 complexes generate currents superficially similar to those
of KCNQ1-KCNE1, but with much more positive activation volt-
ages (Angelo et al., 2002), suggesting either an inhibitory role for
KCNE5 (originally termed KCNE1L), or perhaps an as-yet not
understood role in more populous complexes with other KCNEs.
KCNE4 and KCNE5 gene variants that dampened their inhibitory
effects on KCNQ1 (gain-of-function mutants) also associate with
AF (Ravn et al., 2008; Ohno et al., 2011) (Table S1).
KCNE MODULATION OF THE Kv4 α SUBUNITS UNDERLYING
HUMAN VENTRICULAR Ito
Human ventricular cardiomyocyte action potentials exhibit a
sharp peak and a notch, as depolarization primarily by Na+
influx is curtailed abruptly by K+ exiting through rapidly acti-
vating Kv channels. The channels whose primary task is to stem
phase 0 depolarization are, in human heart, the Kv4.2 and Kv4.3
channels, via generation of the transient outward Kv current (Ito).
This current is transient because both channel types also inac-
tivate rapidly. KCNE subunits regulate Kv4.2 and Kv4.3 when
co-expressed in vitro, and it is thought that this type of regula-
tion also occurs in human heart (Zhang et al., 2001; Niwa and
Nerbonne, 2010).
Kv4 channels are also regulated by the cytoplasmic KChIP2
subunit in vivo, and KCNEs can regulate Kv4-KChIP2 complexes.
KCNE1 and KCNE3-5 subunits each accelerate Kv4.3-KChIP2
inactivation, while KCNE2 slows inactivation and induces an
overshoot of inactivation recovery in vitro in CHO cells, simi-
lar to that observed in human heart for Ito. KCNE2 augments
Kv4.2 current by mechanisms including slowing of inactivation
(Radicke et al., 2006); although also slowing Kv4.3 inactivation,
KCNE2 reduces its peak current in vitro (Liu et al., 2006;Wu et al.,
2010). KCNE subunits also modulate Kv4 channel pharmacology
and temperature sensitivity (Radicke et al., 2008, 2009, 2013).
Inherited loss-of-function sequence variants in the cardiac
Nav1.5 channel α subunit gene (SCN5A) are the most common
identified genetic cause of Brugada Syndrome (BrS), a lethal
ventricular arrhythmia (Brugada et al., 2006). More recently, BrS-
associated KCNE gene variants have emerged that augment Kv4
currents, mimicking SCN5A loss of function (Delpon et al., 2008;
Ohno et al., 2011; Nakajima et al., 2012) (Table S1). These are
rare, and like the majority of KCNE arrhythmia-associated gene
variants, are not backed by familial analyses or the statistical con-
fidence that comes with prevalence in large cohorts. However,
they have been given some credence in the field, largely because
their effects in vitro are consistent with what would be predicted
from work with SCN5A (which is strongly statistically linked
to BrS), and they occur in BrS patients lacking SCN5A gene
mutations.
ARRHYTHMOGENIC KCNE GENE VARIANTS: TWO DECADES
OF DISCOVERY
The first KCNE gene variant identified in the human popula-
tion was the KCNE1 S38G polymorphism (Lai et al., 1994). The
majority of people harbor one S and one G allele, with the
38GG genotype being next most common, and the 38SS being
the least common (∼10%, depending on the population stud-
ied). S38G genotype reportedly influences predisposition to both
AF and LQTS (Fatini et al., 2006; Prystupa et al., 2006; Xu et al.,
2008; Husser et al., 2009), and heart failure (Fatini et al., 2010),
depending on factors including sex, age, BMI, diabetes, fibrino-
gen, hypercholesterolemia, hypertension, and another KCNE1
SNP (Friedlander et al., 2005).
The first KCNE gene variant to be identified as pathologic was
D76N, a dominant-negative mutation that causes JLNS (Schulze-
Bahr et al., 1997) and impairs KCNQ1-KCNE1 current by a
combination of reduced unitary conductance and impaired gat-
ing. This was closely followed by discovery of S74L, which like
D76N shifts the voltage dependence of activation and accelerates
KCNQ1-KCNE1 channel closing (Splawski et al., 1997; Sesti and
Goldstein, 1998).
The next KCNE gene to be associated with cardiac arrhyth-
mia was KCNE2, with discovery of the rare M54T, I57T, A116V
loss-of-function mutants, and the T8A and Q9E polymorphisms
(Abbott et al., 1999; Sesti et al., 2000). T8A, harbored by >1%
of US Caucasians, is pathogenic only in combination with drug
interaction, as it has no apparent effects without drug but results
in loss of a glycosylation site that shields hERG-KCNE2 channels
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from block by sulfamethoxazole (Sesti et al., 2000; Park et al.,
2003). Q9E, represented in 1–2% of African Americans, impairs
channel function slightly without drug, and also increases sensi-
tivity of hERG-KCNE2 to block by macrolide antibiotics (Abbott
et al., 1999; Ackerman et al., 2003).
Following these findings and the cloning of KCNE3-5, gene
variants in all five KCNE genes have been associated with LQTS,
BrS, and/or AF (Table S1). KCNE3 variants are implicated in
AF, BrS6, and LQTS (Zhang et al., 2005; Delpon et al., 2008;
Ohno et al., 2009). KCNE4 E45D augments KCNQ1-KCNE4 cur-
rent and was discovered in a Chinese patient with AF (Zeng
et al., 2007). KCNE5 gene variants include AF-associated L65F
and BrS/idiopathic ventricular fibrillation-associated Y81H and
D92E/E93X (Ohno et al., 2011). In contrast, the KCNE5-C97T
polymorphism may be protective against AF (Ravn et al., 2005).
Reported KCNE sequence variants in arrhythmias offer as
yet scant information on which to make concrete links between
types/positions of sequence variants and classes of arrhythmia.
However, some patterns emerge when contemplating the 49 vari-
ants that fall into the category of point mutants causing single
amino acid changes (Figure 2), of the 59 reported KCNE vari-
ants for which we consider sufficient evidence is available that
they at least be seriously considered as having a pathogenic role
in the heart (Table S1). These are variants reported absent in con-
trol patients sequenced in the same study, and/or those for which
cellular electrophysiology is consistent with disease association.
For KCNE1 and KCNE2, pathogenic mutations in the transmem-
brane domain occur with a periodicity suggestive of the known
α-helicity of this region, perhaps indicating disruption of the face
most important to α subunit gating. BrS-associated KCNE vari-
ants cluster on the intracellular side; AF-associated variants in
KCNE1-3 cluster in the extracellular region, whereas the opposite
is true for KCNE4 and 5 (Figure 2).
To conclude, KCNE proteins are essential for normal cardiac
function, and human genetics studies are essential in our under-
standing of this. However, human KCNE gene variants are mostly
quite rare and typically lacking familial linkage, therefore some
of the listed variants come into the category of genetic noise—
variants that happen to be found in patients but do not contribute
to the arrhythmia (Kapplinger et al., 2013). Also, in addition
to their partnering promiscuity, all KCNE genes are expressed
in multiple extracardiac tissues (McCrossan and Abbott, 2004).
Therefore, KCNE sequence variants may manifest in multiple
tissues, and these pathologies could indirectly impact cardiac
function both electrically and structurally, further complicat-
ing our efforts to comprehend KCNE-related cardiac diseases.
Comparatively little is known of the extracardiac effects of human
KCNE gene disruption: the KCNE1-linked inner ear defect in
JLNS, and genome-wide association studies showing statistical
linkage to early-onset myocardial infarction and reduced lung
capacity (Kathiresan et al., 2009; Soler Artigas et al., 2011). In con-
trast, mouse Kcne genes are known to be important in, e.g., the
kidneys, adrenals, stomach, colon, airways, and thyroid (Arrighi
et al., 2001; Dedek and Waldegger, 2001; Barriere et al., 2003;
Rivas and Francis, 2005; Roepke et al., 2006, 2009, 2011a,b;
Preston et al., 2010), and in some cases dysfunction of these
tissues has been demonstrated to negatively impact the heart
(Roepke et al., 2009; Hu et al., 2013, 2014). Kcne knockout mouse
studies are providing invaluable inroads into the maze of KCNE
physiology and disease, and constitute a substrate for future
human genetics studies necessary for extrapolation of mouse data
to human systems.
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